Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EWTX Edgewise Therapeutics, Inc.

已收盘 11-26 16:00:00 EST

32.08

+0.10

+0.31%

盘后32.08

+0.000.00%

17:13 EST

最高32.57	最低31.53	成交量32.83万
今开32.20	昨收31.98	日振幅3.25%
总市值30.38亿	流通市值18.88亿	总股本9,469万
成交额1,049万	换手率0.56%	流通股本5,885万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EWTX","market":"US","secType":"STK","nameCN":"Edgewise Therapeutics, Inc.","latestPrice":32.08,"timestamp":1732654800000,"preClose":31.98,"halted":0,"volume":328274,"hourTrading":{"tag":"盘后","latestPrice":32.08,"preClose":32.08,"latestTime":"17:13 EST","volume":10505,"amount":336990.12,"timestamp":1732659223517},"delay":0,"floatShares":58845646,"shares":94688517,"eps":-1.463546,"marketStatus":"已收盘","marketStatusCode":5,"change":0.1,"latestTime":"11-26 16:00:00 EST","open":32.2,"high":32.57,"low":31.53,"amount":10493102.455136,"amplitude":0.03252,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.463546,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732698000000},"adr":0,"listingDate":1616731200000,"adjPreClose":31.98,"postHourTrading":{"tag":"盘后","latestPrice":32.08,"preClose":32.08,"latestTime":"17:13 EST","volume":10505,"amount":336990.12,"timestamp":1732659223517},"volumeRatio":0.813697,"impliedVol":1.1866,"impliedVolPercentile":0.7826},"requestUrl":"/m/hq/s/EWTX","defaultTab":"news","newsList":[{"id":"2483218306","title":"Edgewise Therapeutics, Inc.2024财年第三财季实现净利润-34.13百万美元，同比减少32.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483218306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483218306?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日，Edgewise Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-34.13百万美元，同比减少32.75%；其中营业收入为0.00美元，每股基本收益为-0.36美元。从资产负债表来看，Edgewise Therapeutics, Inc.总负债22.41百万美元，其中短期债务992000.00美元，资产负债比为0.23，流动比率为0.27。机构评级：截至2024年11月16日，当前有6家机构对Edgewise Therapeutics, Inc.目标价做出预测，其中目标均价为43.17美元，其中最低目标价为33.00美元，最高目标价为51.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000316a23b89cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000316a23b89cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","EWTX"],"gpt_icon":0},{"id":"2483513358","title":"Edgewise Therapeutics, Inc.盘中异动 下午盘大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483513358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483513358?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:38","pubTimestamp":1731526720,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时38分，Edgewise Therapeutics, Inc.股票出现异动，股价快速下跌5.06%。截至发稿，该股报33.42美元/股，成交量32.2608万股，换手率0.34%，振幅6.39%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为619.13%、553.18%、161.95%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为139.00%、86.83%、73.71%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033841a234ea0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114033841a234ea0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","BK4007","EWTX"],"gpt_icon":0},{"id":"2483082300","title":"美国研究综述-AMN 医疗保健服务公司、Chart Industries 公司、家得宝公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2483082300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483082300?lang=zh_cn&edition=full","pubTime":"2024-11-13 19:30","pubTimestamp":1731497406,"startTime":"0","endTime":"0","summary":"    路透11月13日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 AMN 医疗保健服务公司、Chart Industries 公司和家得宝公司。* 908 Devices Inc   ：Leerink Partners将目标价从12美元下调至4美元             * 908 Devices Inc   ：Leerink Partners 将其目标价从 \"跑赢大盘 \"下调至 \"跑输大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSX","LU2133065610.SGD","BLTE","ALB","IRON","DAY","BBIO","ARCH","AMN","ABBV","LU0256863902.USD","BHVN","EWTX","COTY","LU2106854487.HKD","DOX","GTLS","BK4505","ALIT","ATLC","DCOM","HD","DOCS","FDX","CLF","HCSG","CHGG","AISP","ACLX","BK4566","CHH","CHRW","MASS","CCCS","SATS","AXSM","CRNX","AESI","LU2249611893.SGD","BK4534","COGT","BLFS","COLD","LU0128525689.USD","LU2065731478.USD","BK4567","BMY","CAVA","APA","BCAX"],"gpt_icon":0},{"id":"2481587130","title":"Edgewise Therapeutics, Inc.盘中异动 下午盘大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481587130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481587130?lang=zh_cn&edition=full","pubTime":"2024-11-08 02:47","pubTimestamp":1731005250,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日02时47分，Edgewise Therapeutics, Inc.股票出现异动，股价快速下挫5.02%。截至发稿，该股报34.78美元/股，成交量39.4834万股，换手率0.42%，振幅5.68%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Celularity Inc.、Celularity Inc C/Wts 16/07/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为935.26%、495.75%、119.36%，振幅较大的相关个股有Celularity Inc.、Celularity Inc C/Wts 16/07/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为258.62%、193.53%、72.18%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110802473098e41453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110802473098e41453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EWTX","BK4539","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2474059637","title":"美国研究综述-ANI Pharmaceuticals、Deere & Co、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2474059637","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474059637?lang=zh_cn&edition=full","pubTime":"2024-10-11 15:47","pubTimestamp":1728632832,"startTime":"0","endTime":"0","summary":"    路透10月11日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 ANI 制药公司、迪尔公司和 Zoetis 公司。要闻 * ANI 制药公司   ：Piper Sandler给予该公司增持评级 * 迪尔公司   ：摩根大通将目标价从 360 美元上调至 420 美元 * Zoetis Inc   ：摩根大通将目标价从22美元上调至230美元 以下是路透周五报道的美国公司研究行动摘要。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAPA","LU0211326839.USD","WLK","LU0158827948.USD","LU1989764664.SGD","LU1983299246.USD","LU2264538146.SGD","BK4152","ANIP","ZTS","XNCR","LU0128525689.USD","LU1868837136.USD","LU0061475181.USD","IE00BLSP4452.SGD","BK4524","ISRG","BK4082","LU0417517546.SGD","LU1989763690.USD","IDXX","LU2271345857.HKD","BK4500","LU1244550494.USD","FLUT","CC","DPZ","LU0058720904.USD","EWTX","LU1804176565.USD","LU0971096721.USD","LU1989763427.SGD","LU1119994496.HKD","ARHS","LU0310799852.SGD","LU0690374961.EUR","DE","HUN","CE","DAL","LU0208291251.USD","BK4539","EMN","LU0256863811.USD","LU0289739343.SGD","LU0158827781.USD","SGXZ23171101.USD","LU0097036916.USD"],"gpt_icon":1},{"id":"2474229730","title":"Edgewise Therapeutics, Inc.盘中异动 早盘快速上涨5.05%报29.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474229730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474229730?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:17","pubTimestamp":1728483437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时17分，Edgewise Therapeutics, Inc.股票出现异动，股价快速上涨5.05%。截至发稿，该股报29.93美元/股，成交量24.3058万股，换手率0.26%，振幅4.46%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为662.30%、316.69%、153.55%，振幅较大的相关个股有Inhibikase Therapeutics, Inc.、Cue Biopharma, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为42.02%、39.02%、19.67%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009221718a1df6d16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009221718a1df6d16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","LENZ","EWTX"],"gpt_icon":0},{"id":"2470448272","title":"Edgewise Therapeutics, Inc.盘中异动 快速下跌5.02%报25.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470448272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470448272?lang=zh_cn&edition=full","pubTime":"2024-09-25 02:12","pubTimestamp":1727201539,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日02时12分，Edgewise Therapeutics, Inc.股票出现波动，股价急速下挫5.02%。截至发稿，该股报25.16美元/股，成交量42.8638万股，换手率0.46%，振幅5.83%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为4528.64%、198.00%、176.35%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Onconetix, Inc.，振幅分别为122.95%、58.52%、45.08%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502121998e38b53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092502121998e38b53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","EWTX","LENZ"],"gpt_icon":0},{"id":"2468917646","title":"美国研究综述-Factset、联邦快递、赛默飞世尔科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2468917646","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468917646?lang=zh_cn&edition=full","pubTime":"2024-09-20 15:20","pubTimestamp":1726816830,"startTime":"0","endTime":"0","summary":"    路透9月20日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Factset、联邦快递和赛默飞世尔科技。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDA","LU2210149790.SGD","IE00BMG7P702.HKD","IE00B3T34201.USD","BK4519","IE00B19Z8X17.USD","MPC","GIS","LU0114720955.EUR","ALL","AEP","PNW","GLW","IQV","FDX","LU0342679015.USD","LU2063271972.USD","BK4504","FDS","LU2065170008.USD","OGE","AEE","DUK","IE0009355771.USD","PSX","DRI","DINO","LU2095319765.USD","DNA","PARR","PSTL","D","LNT","ASMB","DK","TMO","CRL","LU1854103824.USD","LU0957791311.USD","MEDP","AJG","ENVA","EXC","PBF","LU2210150020.SGD","EWTX","IE00BVYPNV92.GBP","LH","EVRG","LU1670628061.USD"],"gpt_icon":1},{"id":"2468042765","title":"BUZZ--美国股票走势-Spotify、Coursera、Tandem 糖尿病护理公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2468042765","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468042765?lang=zh_cn&edition=full","pubTime":"2024-09-20 00:05","pubTimestamp":1726761931,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月19日 - 在美联储以削减半个百分点开启宽松周期并预测将有更多削减后，华尔街周四反弹，标普500指数再创盘中纪录新高。美东时间11:34，道琼斯工业平均指数  上涨1.02%，报41,927.77点。标普500指数  上涨1.66%，报5711.6点；纳斯达克综合指数  上涨2.66%，报18040.538点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["2NVD.UK","NQmain","TOL","3NVD.UK","DJX","BANC","PHM","ANGL","DASH","DHI",".DJI","COUR","TNDM",".IXIC","AHR","KEY","ELAN","EWTX","VST","DOG","LEN","DXD","CRMT","SPOT","LU","CRK","UDOW","HESM","TGT","DRI","KBH","TQQQ","IEF","SQQQ","VNDA","MBLY","FITB","FDS"],"gpt_icon":1},{"id":"2468506319","title":"BUZZ-Edgewise Therapeutics 因心脏病药物的早期数据而跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2468506319","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468506319?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:59","pubTimestamp":1726757964,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    9月19日 - ** 药物开发商Edgewise Therapeutics   股价飙升45%，创下27.66美元的逾3年新高  ** 该公司称其治疗心脏病的实验性药物在一项早期研究中耐受性良好 ** EDG-7500 是一种用于治疗阻塞性肥厚型心肌病的药物，这种疾病会导致心肌增厚，增加心脏泵血的难度。 ** Truist Securities 分析师认为：\"早期数据表明，该药物正在发挥预期作用。 ** Truist将EWTX的PT值从25美元上调至33美元，较上一交易日收盘价上涨73%。** 包括盘中涨幅在内，该股今年累计涨幅超过一倍","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","EWTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2468076572","title":"Edgewise Therapeutics, Inc.盘中异动 早盘大幅上涨35.03%报25.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468076572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468076572?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:30","pubTimestamp":1726752605,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时30分，Edgewise Therapeutics, Inc.股票出现异动，股价快速上涨35.03%。截至发稿，该股报25.75美元/股，成交量184.455万股，换手率1.97%，振幅0.00%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Edgewise Therapeutics, Inc.、Seres Therapeutics, Inc.、Candel Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为991.18%、299.68%、66.56%，振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.，振幅分别为0.00%、0.00%、0.00%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213006a1db30ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213006a1db30ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","EWTX","LENZ"],"gpt_icon":0},{"id":"2461188796","title":"Edgewise Therapeutics, Inc.盘中异动 大幅拉升5.13%报19.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461188796","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461188796?lang=zh_cn&edition=full","pubTime":"2024-08-21 01:39","pubTimestamp":1724175546,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日01时39分，Edgewise Therapeutics, Inc.股票出现异动，股价快速拉升5.13%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Cingulate Inc.较为活跃，换手率分别为3522.94%、2468.06%、799.17%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、泰坦制药、Biomotion Sciences C/Wts Exp 15/08/2029 ，振幅分别为274.86%、128.68%、78.89%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082101390698e35938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082101390698e35938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EWTX","BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"1183248636","title":"异动解读 | Edgewise Therapeutics盘中大涨7.45% 机构看好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1183248636","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183248636?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:30","pubTimestamp":1723739425,"startTime":"0","endTime":"0","summary":"北京时间2024年8月15日,生物制药公司Edgewise Therapeutics, Inc.股价在盘中出现大涨,最高上涨7.45%,报收17.95美元/股。公开消息显示,EWTX股价在当日盘中一度急速拉升5.28%,引发市场关注。分析人士认为,这可能与机构对该公司前景看好有关。Edgewise Therapeutics是一家临床阶段的生物制药公司,专注于开发治疗严重罕见肌肉疾病的创新疗法。公司正在研发口服小分子药物治疗肌肉骨骼疾病,在这一领域具有较强的竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX"],"gpt_icon":0},{"id":"2459223477","title":"Edgewise Therapeutics, Inc.2024财年第二财季实现净利润-31.50百万美元，同比减少46.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459223477","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459223477?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:03","pubTimestamp":1723737809,"startTime":"0","endTime":"0","summary":"8月16日，Edgewise Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-31.50百万美元，同比减少46.72%；其中营业收入为0.00美元，每股基本收益为-0.34美元。从资产负债表来看，Edgewise Therapeutics, Inc.总负债21.17百万美元，其中短期债务988000.00美元，资产负债比为0.26，流动比率为0.31。机构评级：截至2024年8月16日，当前有6家机构对Edgewise Therapeutics, Inc.目标价做出预测，其中目标均价为33.17美元，其中最低目标价为25.00美元，最高目标价为48.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000336959be702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000336959be702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","EWTX"],"gpt_icon":0},{"id":"2459420495","title":"Edgewise Therapeutics, Inc.盘中异动 急速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420495","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420495?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:31","pubTimestamp":1723728667,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时31分，Edgewise Therapeutics, Inc.股票出现异动，股价急速拉升5.28%。截至发稿，该股报17.95美元/股，成交量9182股，换手率0.01%，振幅1.58%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为2303.07%、1455.32%、333.77%，振幅较大的相关个股有Cingulate Inc.、Celcuity Inc.、Absci Corporation，振幅分别为28.18%、9.31%、9.11%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213107a1d47055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213107a1d47055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","BK4539","EWTX"],"gpt_icon":0},{"id":"2458749620","title":"美国研究综述-Airbnb、通用美元、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2458749620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458749620?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:40","pubTimestamp":1723448430,"startTime":"0","endTime":"0","summary":"    路透8月12日 - 华尔街证券分析师周一调整了对多家美国上市公司的评级和目标价，其中包括 Airbnb、Dollar General 和沃尔玛。要闻             * Airbnb Inc   ：杰富瑞将目标价从 150 美元下调至 125 美元              * Dollar General Corp   ：杰富瑞将目标价从160美元下调至145美元             * Hilton Grand Vacations Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Pacira Biosciences Inc   ：摩根大通将目标价从45美元下调至10美元              * Pacira Biosciences Inc   ：Piper Sandler将目标价从42美元下调至11美元             * Pacira Biosciences Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CC","BK4535","HSIC","LU2361045086.USD","PCRX","ROK","NNI","STEP","EWTX","GHLD","LU1069347547.HKD","OKE","IE0034390439.USD","FMC","FTDR","BK4173","BJ","PX","SWIM","HLMN","OPAD","LEGH","HBI","CBUS","CARG","LU2361044865.SGD","BK4175","LU1066051225.USD","HGV","LU0211327993.USD","RDFN","BURL","ZD","EXPE","DG","DLTR","WMT","ABNB","SKY","LU2361044949.HKD","GCMG","ITOS","NTLA","CCOI","ARDT","BWIN","RDNT","GSHD","BTAI"],"gpt_icon":1},{"id":"2457077846","title":"Edgewise Therapeutics Inc    预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457077846","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457077846?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:32","pubTimestamp":1722969162,"startTime":"0","endTime":"0","summary":"   * Edgewise Therapeutics Inc    预计在8月8日公布截至0001年1月1日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Edgewise Therapeutics Inc的平均预期是每股亏损34美分。* 华尔街对 Edgewise Therapeutics Inc 的 12 个月目标价中位数为 32.00 美元，高于其上次收盘价 15.89 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX","LENZ"],"gpt_icon":0},{"id":"2454328342","title":"Edgewise Therapeutics, Inc.盘中异动 股价大涨5.05%报19.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454328342","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454328342?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:44","pubTimestamp":1722001474,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时44分，Edgewise Therapeutics, Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报19.68美元/股，成交量5.1848万股，换手率0.06%，振幅4.54%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Windtree Therapeutics, Inc.、Nutriband Inc C/Wts 、Cel-Sci Corporation涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃，换手率分别为3555.08%、114.52%、57.42%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Cel-Sci Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为56.23%、49.58%、26.50%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214435af945996&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214435af945996&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","EWTX","BK4539"],"gpt_icon":0},{"id":"2454382913","title":"成分股MeiraGTx收涨11.62%，AC Immune涨10.76%，诺瓦瓦克斯医药涨8.25%表现第三，和黄医药则收跌3.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454382913","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454382913?lang=zh_cn&edition=full","pubTime":"2024-07-26 04:45","pubTimestamp":1721940358,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["JANX","BK4588","BK4139","BK1588","HCM","BK4007","BK4539","AC","BK1587","EWTX","BK4568","NVAX","BK4547","BK1191","BK4135","BK4531","00013","LENZ","BK4585"],"gpt_icon":0},{"id":"2450824715","title":"成分股uniQure收涨51.72%，延续7月9日涨76.46%的表现；Amylyx Pharmaceutical涨25.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450824715","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450824715?lang=zh_cn&edition=full","pubTime":"2024-07-11 06:37","pubTimestamp":1720651031,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["KYMR","FULC","AMRN","OCUL","BK4007","BK4539","BK4139","ZNTL","LENZ","EWTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.edgewisetx.com","stockEarnings":[{"period":"1week","weight":0.0386},{"period":"1month","weight":-0.0858},{"period":"3month","weight":0.6168},{"period":"6month","weight":0.8593},{"period":"1year","weight":3.9428},{"period":"ytd","weight":1.9232}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Edgewise Therapeutics, Inc.于2017年5月成立为特拉华州公司，总部位于科罗拉多州博尔德。 该公司是一家临床阶段的生物制药公司，致力于发现，开发和商业化针对严重，罕见的肌肉疾病的新疗法，这些药物对于医疗的需求尚未得到充分满足。公司的主要候选产品EDG-5506是一种口服小分子药物，旨在解决营养不良症的根本原因，包括杜氏肌营养不良（DMD）和贝克尔肌营养不良（BMD）。针对主要肌肉蛋白质和调节剂的精密药物候选产品的渠道，以解决广泛的遗传定义的肌肉疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.221382},{"month":2,"riseRate":0,"avgChangeRate":-0.093585},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.121355},{"month":4,"riseRate":0.25,"avgChangeRate":0.000577},{"month":5,"riseRate":0.5,"avgChangeRate":-0.024995},{"month":6,"riseRate":0.5,"avgChangeRate":-0.042597},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019509},{"month":8,"riseRate":0.5,"avgChangeRate":-0.023659},{"month":9,"riseRate":0.5,"avgChangeRate":0.091109},{"month":10,"riseRate":0.5,"avgChangeRate":0.083785},{"month":11,"riseRate":0.25,"avgChangeRate":-0.025123},{"month":12,"riseRate":0.333333,"avgChangeRate":0.225126}],"exchange":"NASDAQ","name":"Edgewise Therapeutics, Inc.","nameEN":"Edgewise Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Edgewise Therapeutics, Inc.(EWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Edgewise Therapeutics, Inc.,EWTX,Edgewise Therapeutics, Inc.股票,Edgewise Therapeutics, Inc.股票老虎,Edgewise Therapeutics, Inc.股票老虎国际,Edgewise Therapeutics, Inc.行情,Edgewise Therapeutics, Inc.股票行情,Edgewise Therapeutics, Inc.股价,Edgewise Therapeutics, Inc.股市,Edgewise Therapeutics, Inc.股票价格,Edgewise Therapeutics, Inc.股票交易,Edgewise Therapeutics, Inc.股票购买,Edgewise Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Edgewise Therapeutics, Inc.(EWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}